It is also demonstrated that gamma-tubulin complex protein-5 (GPC5) competitively bound Wnt3a to inactivate the Wnt/β-catenin signaling pathway and inhibited the EMT of lung cancer cells (Wang S. et al., 2016). This evidence concerns the gene GPC5 and lung cancer.